Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2009 1
2011 1
2017 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: srategic
Page 1
Cost Offset Associated With Early Start Denver Model for Children With Autism.
Cidav Z, Munson J, Estes A, Dawson G, Rogers S, Mandell D. Cidav Z, et al. J Am Acad Child Adolesc Psychiatry. 2017 Sep;56(9):777-783. doi: 10.1016/j.jaac.2017.06.007. Epub 2017 Jul 4. J Am Acad Child Adolesc Psychiatry. 2017. PMID: 28838582 Free PMC article. Clinical Trial.
OBJECTIVE: To determine the effect of the Early Start Denver Model (ESDM) for treatment of young children with autism on health care service use and costs. ...The higher cost of ESDM was partially offset during the intervention period because children in the ESDM group use …
OBJECTIVE: To determine the effect of the Early Start Denver Model (ESDM) for treatment of young children with autism on health care …
Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study.
Banach M, Lewek J, Pol K, Rabczenko D, Balanescu SM, Blaha V, Ceska R, Jankowski P, Surma S, Kolovou G, Liberopoulos E, Mitu F, Mitu M, Naji FH, Paragh G, Popławska M, Vrablik M, Pella D. Banach M, et al. Front Cardiovasc Med. 2023 Jun 19;10:1206551. doi: 10.3389/fcvm.2023.1206551. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37404744 Free PMC article.
Thus, we aimed to compare the differences in physicians' therapeutic decisions on alirocumab dose selection, and factors affecting these in CEE countries vs. other countries included in the ODYSSEY APPRISE study. METHODS: ODYSSEY APPRISE was a prospective, single-arm, phas …
Thus, we aimed to compare the differences in physicians' therapeutic decisions on alirocumab dose selection, and factors affecting these in …
Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.
Velasco-Sánchez D, Aracil A, Montero R, Mas A, Jiménez L, O'Callaghan M, Tondo M, Capdevila A, Blanch J, Artuch R, Pineda M. Velasco-Sánchez D, et al. Cerebellum. 2011 Mar;10(1):1-8. doi: 10.1007/s12311-010-0212-7. Cerebellum. 2011. PMID: 20865357
Posture and gait scores increased significantly after 11 months of therapy (Wilcoxon's test, p = 0.04) and kinetic function improved significantly (Wilcoxon's test, p = 0.015). Echocardiography data showed a significant reduction of the interventricular septum thickness (W …
Posture and gait scores increased significantly after 11 months of therapy (Wilcoxon's test, p = 0.04) and kinetic function improved signifi …
[Parkinsonism probably induced by manganese].
Durán E, Chacón JR. Durán E, et al. Rev Neurol. 2001 Sep 1-15;33(5):434-6. Rev Neurol. 2001. PMID: 11727210 Free article. Spanish.
She denied taking drugs, having dysphagia, dysarthria, visual changes or sphincter disorders. Neurological examination showed her to have monotonous speech, slight facial hypomimia, slight reduction in spontaneous blinking, walking with less swing of her right ar …
She denied taking drugs, having dysphagia, dysarthria, visual changes or sphincter disorders. Neurological examination showed her to have mo …
Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A, Stollhoff K, Ossig W, Unkelbach S, Lüer W, Bogdanow M, Schauble B; TOPMAT-EPY-403 investigators. Schreiner A, et al. Acta Neurol Scand. 2009 May;119(5):304-12. doi: 10.1111/j.1600-0404.2008.01130.x. Acta Neurol Scand. 2009. PMID: 19133865 Clinical Trial.
TPM was added onto the existing antiepileptic drug (AED) treatment and started at a dose of 25 mg once daily. The dose was titrated up with 25 mg/day increments, once every 1-2 weeks, until a final dose between 50-200 mg/day was reached. ...At study endpoint, the intended …
TPM was added onto the existing antiepileptic drug (AED) treatment and started at a dose of 25 mg once daily. The dose was titrated u …